The healthcare landscape for diabetes is shifting, and GLP-1 patches represent a potential development. Unlike shots, this approach offers a less invasive way to provide GLP-1 drugs. These transdermal systems slowly release the drug through the skin offering a stable level of the therapeutic agent, which can optimize blood sugar control and possibl